1. Sign our petition calling on Cochrane to withdraw their review of Exercise Therapy for CFS here.
    Dismiss Notice
  2. Guest, the 'News in Brief' for the week beginning 15th April 2024 is here.
    Dismiss Notice
  3. Welcome! To read the Core Purpose and Values of our forum, click here.
    Dismiss Notice

Review: Updates in Functional Movement Disorders: from Pathophysiology to Treatment Advances, 2022, Kola and LaFaver

Discussion in 'Other psychosomatic news and research' started by Andy, Apr 21, 2022.

  1. Andy

    Andy Committee Member

    Messages:
    21,947
    Location:
    Hampshire, UK
    Abstract
    Purpose of Review

    This review discusses advances in functional movement disorders (FMD) over the past 3 years, with a focus on risk factors, diagnosis, pathophysiology, neuroimaging studies, and treatment.

    Recent Findings
    The past decade has brought a revived interest in functional movement disorders, with a growing number of studies exploring pathophysiological mechanisms. Here, we review recent studies demonstrating changes in attention, emotional and sensorimotor function in FMD. Through international collaborative efforts, progress has been made in defining biomarkers and outcome measures, an important prerequisite towards standardization of diagnosis and reporting of outcomes in clinical trials. Of particular interest are neuroimaging studies demonstrating functional and structural changes in motor and emotional brain circuits, deepening our understanding of FMD as a neurocircuit disorder and potentially paving the way towards new treatments. Currently available treatment modalities have shown successful outcomes via outpatient, inpatient, and virtual delivery.

    Summary
    The last 3 years have seen tremendous efforts to better understand, diagnose, and treat FMD. The disease model has been broadened to include a biopsychosocial formulation, and insights on the pathophysiology on FMD are informing treatment efforts. Several international multidisciplinary research collaborations are underway to define biomarkers and best outcome measures, highlighting the path towards improved standardization of future treatment trials. Additionally, the rise of telemedicine during the COVID-19 pandemic has reduced geographic barriers and paved the way for virtual therapy sessions and self-guided programs.

    Open access, https://link.springer.com/article/10.1007/s11910-022-01192-9
     
    Peter Trewhitt and DokaGirl like this.
  2. Mithriel

    Mithriel Senior Member (Voting Rights)

    Messages:
    2,816
    If functional movement disorders were really caused by emotional and psychological problems the present treatments would be very successful so there would not need to be a search for new ones. Pathophysiology sounds suspiciously like thye now think there is a hardware problem!
     
    Sean, Peter Trewhitt, rvallee and 2 others like this.

Share This Page